bioRxiv · 10.1101/2025.07.08.663720
Tumor-infiltrating CD27-IgD- regulatory B cells suppress cytotoxic CD8+T cell responses in renal cell carcinoma
Abstract
B cells play a pivotal role in shaping the tumor microenvironment (TME) and tertiary lymphoid structures (TLS), but the functions of specific B cell subsets in cancer pathogenesis remain unclear. Using a novel tissue-centric single cell RNA-sequencing (scRNA-seq) bioinformatic workflow aimed at unraveling cancer-specific clusters, combined with flow cytometry and high-plex spatial imaging, we identify a renal cell carcinoma (RCC)-specific enrichment of CD27-IgD-CD21+CD11c- double negative 1 (DN1) B cells associated with worse prognosis and regulatory function. Spatial profiling localizes DN1 Bregs within immature TLSs, in close proximity to IL-10 and TGF{beta}CD8T cells. RCC-resident DN1 B cells are enriched for endosomal Toll-like receptor (TLR) signaling pathways and stimulation of tumor-infiltrating lymphocytes (TILs) with TLR agonists induces the differentiation of IL-10+ and TGF{beta}+DN Bregs suppressing CD8+T cell cytotoxicity, partially via IL-10 and TGF{beta}. These findings identify a pro-tumorigenic B cell population with potential diagnostic and therapeutic relevance in RCC.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Baig, Z., Withnell, I., Ng, J. C. F., Piper, C. J. M., Bradford, H. F., Rullan, A., Arbe-Barnes, E. H., de Brito, C. G. X., Di Tullio, A., Mitchell, T. J., Stauss, H. J., Tran, M. G. B., Fraternali, F., Mauri, C.. 2025-07-12. Tumor-infiltrating CD27-IgD- regulatory B cells suppress cytotoxic CD8+T cell responses in renal cell carcinoma. https://doi.org/10.1101/2025.07.08.663720
Cite the original work for its findings. Save a collection to share your selection of sources.